InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by KISNER DANIEL L, Director. Officer active across 2 companies, notably Zynerba Pharmaceuticals, Inc.. Cumulatively, 7 filings have been published. History available since 3 August 2021. The latest transaction was disclosed on 23 May 2024 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations7 total
5,357 shares0Common StockSEC:0000950170-24-065584:0
27,954 sharesCommon StockSEC:0001140361-23-047722:0
47,824 shares0Common StockSEC:0001062993-23-013666:0
5,357 shares0Common StockSEC:0001209191-23-033165:0
23,109 shares0Common StockSEC:0001062993-22-015042:0
5,000 shares0Common StockSEC:0001192482-21-000644:0
5,000 shares0Common StockSEC:0001192482-21-000644
7 of 7 declarations
About KISNER DANIEL L
Daniel L. Kisner is a Board Member at Zynerba Pharmaceuticals, Inc. He is involved in governance and strategic decision-making. With expertise in the pharmaceutical sector, Daniel contributes to innovation and growth within the company.
